Icon

Isentress - (400 mg; Tablet)

Raltegravir Potassium Merck
400 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
ISENTRESS™ is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
Yes
***** ** *** *** *** ********* *** *** ******* ** *** ******* **** *******. ** *** ****, ***** **** ****** **** ************ ** ****** '***. ********* ** *****'* *** ******, ***** ****** *** ********* ******* ** **** ** *** **.
Isentress Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
****** *** ********* *** ********* *** ********* ******* ***** ******** ************ *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* -**- ******* ********* ******** ******* *** **** *** **** ****
  1. *** **, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** *, **** : ****** ******** ***** ** ***** **** ** ******.
  3. *** **, **** : ****** ******** ********* ******** **** *** *** *** *** *********
  4. *** **, **** : ***** **** ****** **** ************ ** ****** '***.
  5. *** **, **** : ***** *** ****** **** ******* ********** **** ******* *****. ****** ****** ********** ****** **. '***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.